Back

Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity

Pallais, J. P.; Razzoli, M.; Rodriguez, P.; McGonigle, S.; Daugherty, A.; Hillman, H.; Verteramo, L.; Schrank, P.; Parthiban, P.; Chang, X.; Wang, H.; Veglia, G.; Koehl, J.; Bose, M.; Ehrlich, M. E.; Salton, S.; Araque, A.; Lettieri Barbato, D.; Revelo, X.; Ruan, H.-B.; Williams, J. W.; Bartolomucci, A.

2026-04-22 immunology
10.64898/2026.04.18.719397 bioRxiv
Show abstract

Microglia, the resident macrophages of the central nervous system, are recognized for their heterogeneity and integral role in brain function and diseases. In the context of high fat diet (HFD) feeding and obesity, microglia become overactive, acquiring a prevailing lipid associated microglial phenotype (also known as LAM). Yet, how microgliosis is induced and regulated remains unclear. Here we report a key role for the Complement 3a Receptor (C3aR), on HFD-induced hypothalamic gliosis and weight gain in mice. HFD consumption leads to elevated microglial expression of C3aR, which parallels widespread accumulation of reactive microglia, selectively in the hypothalamus. Conditional microglial C3aR deletion protects mice from HFD-induced hypothalamic reactive microgliosis. C3aR deletion or pharmacological antagonism opposes HFD-induced weight gain in male but not female mice. Mechanistically, we demonstrated that C3aR is essential for lipid-induced lipid droplet formation, and acquisition of a LAM molecular signature. In summary, we uncovered a previously unknown role for C3aR in the acquisition of a LAM signature driving diet-induced gliosis, identifying this receptor as a new viable therapeutic candidate for conditions associated with hypothalamic neuroinflammation.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 19%
9.9%
2
Cell Reports
1338 papers in training set
Top 4%
8.2%
3
eLife
5422 papers in training set
Top 14%
6.2%
4
Nature Metabolism
56 papers in training set
Top 0.3%
6.2%
5
Diabetes
53 papers in training set
Top 0.1%
6.2%
6
Immunity
58 papers in training set
Top 1%
4.7%
7
Journal of Clinical Investigation
164 papers in training set
Top 0.6%
4.7%
8
Journal of Neuroinflammation
50 papers in training set
Top 0.2%
3.5%
9
Molecular Metabolism
105 papers in training set
Top 0.6%
3.5%
50% of probability mass above
10
Journal of Experimental Medicine
106 papers in training set
Top 2%
2.0%
11
PLOS Biology
408 papers in training set
Top 7%
2.0%
12
Cell Metabolism
49 papers in training set
Top 0.9%
1.8%
13
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
14
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
1.7%
15
Gastroenterology
40 papers in training set
Top 1%
1.7%
16
Nature Immunology
71 papers in training set
Top 1%
1.5%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
18
Science Advances
1098 papers in training set
Top 20%
1.5%
19
JCI Insight
241 papers in training set
Top 4%
1.5%
20
Science Translational Medicine
111 papers in training set
Top 4%
1.3%
21
iScience
1063 papers in training set
Top 20%
1.3%
22
EMBO Molecular Medicine
85 papers in training set
Top 3%
1.2%
23
Cellular & Molecular Immunology
14 papers in training set
Top 1%
0.9%
24
Cell
370 papers in training set
Top 16%
0.8%
25
Nature
575 papers in training set
Top 15%
0.8%
26
EMBO reports
136 papers in training set
Top 7%
0.7%
27
Science
429 papers in training set
Top 20%
0.7%
28
Journal of Cell Biology
333 papers in training set
Top 5%
0.7%
29
Aging Cell
144 papers in training set
Top 4%
0.7%
30
Metabolism
14 papers in training set
Top 0.5%
0.7%